Lupin informs about acquisition

29 Sep 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, Lupin has informed that Nanomi B.V., the Netherlands (‘Nanomi’), a wholly owned subsidiary of the Company in Netherlands has entered into a definitive agreement to acquire the entire share capital of VISUfarma B.V., headquartered in Amsterdam, the Netherlands. The details required under Regulation 30 and Schedule III of SEBI Listing Regulations, read with the SEBI Master Circular dated November 11, 2024, bearing reference number SEBI/HO/CFD/PoD2/CIR/P/0155 and such other circulars as applicable (‘SEBI Master Circular’), is set at Annexure I. A Press Release along with a brief presentation are also enclosed.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2101.00 9.05 (0.43%)
05-Dec-2025 14:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.80
Dr. Reddys Lab 1275.00
Cipla 1524.60
Zydus Lifesciences 933.35
Lupin 2101.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×